168 related articles for article (PubMed ID: 20097073)
1. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists.
Evans KA; Budzik BW; Ross SA; Wisnoski DD; Jin J; Rivero RA; Vimal M; Szewczyk GR; Jayawickreme C; Moncol DL; Rimele TJ; Armour SL; Weaver SP; Griffin RJ; Tadepalli SM; Jeune MR; Shearer TW; Chen ZB; Chen L; Anderson DL; Becherer JD; De Los Frailes M; Colilla FJ
J Med Chem; 2009 Dec; 52(24):7962-5. PubMed ID: 19902954
[TBL] [Abstract][Full Text] [Related]
3. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.
Li YH; Coppo FT; Evans KA; Graybill TL; Patel M; Gale J; Li H; Tavares F; Thomson SA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5892-6. PubMed ID: 16942879
[TBL] [Abstract][Full Text] [Related]
5. Phenoxyacetic acids as PPARδ partial agonists: synthesis, optimization, and in vivo efficacy.
Evans KA; Shearer BG; Wisnoski DD; Shi D; Sparks SM; Sternbach DD; Winegar DA; Billin AN; Britt C; Way JM; Epperly AH; Leesnitzer LM; Merrihew RV; Xu RX; Lambert MH; Jin J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2345-50. PubMed ID: 21414782
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5.
Herbert MR; Siegel DL; Staszewski L; Cayanan C; Banerjee U; Dhamija S; Anderson J; Fan A; Wang L; Rix P; Shiau AK; Rao TS; Noble SA; Heyman RA; Bischoff E; Guha M; Kabakibi A; Pinkerton AB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5718-21. PubMed ID: 20801037
[TBL] [Abstract][Full Text] [Related]
7. 2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.
Gleave RJ; Beswick PJ; Brown AJ; Giblin GM; Haslam CP; Livermore D; Moses A; Nicholson NH; Page LW; Slingsby B; Swarbrick ME
Bioorg Med Chem Lett; 2009 Dec; 19(23):6578-81. PubMed ID: 19864133
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
[TBL] [Abstract][Full Text] [Related]
9. Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.
Evans KA; Li YH; Coppo FT; Graybill TL; Cichy-Knight M; Patel M; Gale J; Li H; Thrall SH; Tew D; Tavares F; Thomson SA; Weiel JE; Boucheron JA; Clancy DC; Epperly AH; Golden PL
Bioorg Med Chem Lett; 2008 Jul; 18(14):4068-71. PubMed ID: 18554908
[TBL] [Abstract][Full Text] [Related]
10. Identification of new potent GPR119 agonists by combining virtual screening and combinatorial chemistry.
Wellenzohn B; Lessel U; Beller A; Isambert T; Hoenke C; Nosse B
J Med Chem; 2012 Dec; 55(24):11031-41. PubMed ID: 23211099
[TBL] [Abstract][Full Text] [Related]
11. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of 3,4,5-trisubstituted 4,5-dihydro-1,2,4-oxadiazoles as TGR5 agonists.
Zhu J; Ye Y; Ning M; Mándi A; Feng Y; Zou Q; Kurtán T; Leng Y; Shen J
ChemMedChem; 2013 Jul; 8(7):1210-23. PubMed ID: 23757200
[TBL] [Abstract][Full Text] [Related]
14. Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR).
Zhai W; Flynn N; Longhi DA; Tino JA; Murphy BJ; Slusarchyk D; Gordon DA; Pendri A; Shi S; Stoffel R; Ma B; Sofia MJ; Gerritz SW
Bioorg Med Chem Lett; 2008 Sep; 18(18):5083-6. PubMed ID: 18722770
[TBL] [Abstract][Full Text] [Related]
15. Identification of small molecule agonists of the motilin receptor.
Heightman TD; Conway E; Corbett DF; Macdonald GJ; Stemp G; Westaway SM; Celestini P; Gagliardi S; Riccaboni M; Ronzoni S; Vaidya K; Butler S; McKay F; Muir A; Powney B; Winborn K; Wise A; Jarvie EM; Sanger GJ
Bioorg Med Chem Lett; 2008 Dec; 18(24):6423-8. PubMed ID: 18980843
[TBL] [Abstract][Full Text] [Related]
16. Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
Malik L; Kelly NM; Ma JN; Currier EA; Burstein ES; Olsson R
Bioorg Med Chem Lett; 2009 Mar; 19(6):1729-32. PubMed ID: 19230660
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601
[TBL] [Abstract][Full Text] [Related]
18. Isochromanone-based urotensin-II receptor agonists.
Lehmann F; Currier EA; Olsson R; Hacksell U; Luthman K
Bioorg Med Chem; 2005 Apr; 13(8):3057-68. PubMed ID: 15781415
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent, isoxazole-containing renin inhibitors.
Fournier PA; Arbour M; Cauchon E; Chen A; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Grimm E; Han Y; Houle R; Lacombe P; Lévesque JF; MacDonald D; Mackay B; McKay D; Percival MD; Ramtohul Y; St-Jacques R; Toulmond S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2670-4. PubMed ID: 22450130
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
Lescot E; Bureau R; Rault S
Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
